Customer Engagement Uncovering the True Impact of a Black Box Warning ZoomRx’s HCP-Patient dialogue research helped brands understand how HCPs were messaging the safety profile of their JAK product based on clinical data. Access the insights in this case study.
Participating in Paid Medical Surveys: For Doctors & Healthcare Professionals If you’re a medical professional, chances are you have a fair amount of knowledge about the healthcare industry. However, no matter how much experience you have, there will always be new things
Launch Excellence Empowering a leading biotech manufacturer to make data-backed decisions in the eleventh hour [Case Study] Commercial launches move fast and critical decisions need to be made in a matter of days. See how ZoomRx empowered a leading biotech manufacturer with the necessary insights to make data-backed decisions in real time.
Customer Engagement The Current State of Sales Rep Promotion: Key Trends in a Post-COVID-19 World A deep dive into >32,000 in-person and virtual sales rep interactions to examine the impact of the COVID-19 pandemic and uncover key trends in sales rep promotion.
Customer Engagement The Future of Customer Engagement: Digital Pharma Innovation Week 2022 As the communication preferences of healthcare providers continue to evolve, life sciences organizations have invested heavily to explore innovative means for connecting, engaging, and partnering with their key customers. The annual Digital Pharma
Digital Tracker 8 Striking Facts about Biopharma Digital Ads To date, it has been difficult to put into perspective the full breadth of digital promotion HCPs receive. PERxCEPT, a next-generation omnichannel intelligence tool, demonstrates surprising new insights about the digital marketplace.
Oncology The Evolution of Medical Conferences: The New Normal is Here As we move back to a place where in-person conferences are possible, how should these conferences be structured in terms of in-person vs. virtual engagement to achieve success?
Digital Tracker The Top 10 Most Digitally Active Oncology Brands in Q2'22 ZoomRx has ranked the leading oncology brands by their Q2’22 digital activity by collecting banner ad impressions across the entire digital landscape, with the help of ZoomRx's new omnichannel intelligence tool, PERxCEPT.
Oncology 2022 ASCO Annual Meeting: Major Scientific Progress Moves the Field of Oncology Beyond COVID A strong line up of potentially practice-changing presentations generated a great deal of excitement among attendees at ASCO#2022 – both those in person at the McCormick Convention Center and those attending virtually. Based
Customer Engagement ZoomRx Roundtable: Finding Success in Omnichannel Engagement Senior leaders at ZoomRx examine how organizations can make adjustments to their customer strategies and define a path forward for a more cohesive and impactful model of omnichannel engagement.
Digital Tracker PERxCEPT: Omnichannel Intelligence Reimagined PERxCEPT enables you to see exactly what your customers see online, providing unprecedented views into the performance of your competitors’ digital tactics vs that of your own. Take your omnichannel intelligence to the next level with this next-generation tool.
Customer Engagement ZoomRx Roundtable: Identifying key challenges in Omnichannel Engagement The best path to optimizing your omnichannel customer engagement strategy begins with identifying common roadblocks facing teams in life sciences. Industry experts at ZoomRx identify the key challenges and discuss how to chart a course toward successful omnichannel engagement.
Digital Tracker Optimize Your Digital Strategy with Enhanced Competitive Insights The stakes for digital marketing strategies in pharmaceutical markets have never been higher, but too often pharma marketers are left in the dark. PERxCEPT helps pharma marketers get a deeper understanding of both their customers and competitors, enabling them to spend smarter.
Conferences Recent Advances in Multiple Myeloma (ASH 2021) Data that was released during the American Society of Hematology (ASH) 2021 meeting represents significant progress in the field and will have a positive impact on patients’ lives. Below are a few of
Oncology Oncologists' Perspectives on Recent Developments in Advanced Breast Cancer: Promising Progress with Curative Intent Just Out of Reach Recent developments across three subtypes of advanced breast cancer – HER2+, TNBC, and HR+/HER2- have generated enthusiasm among oncologists in the United States. While oncologists are stopping short of calling advanced breast cancer
Covid-19 Committing To Support COVID-19 Relief and Rehabilitation Seeing an unprecedented threat to public health and the livelihood of millions, we wanted to get directly involved and do our part in aiding the country’s recovery. To achieve this, ZoomRx pledged a relief fund dedicated solely toward COVID-19 response and recovery.
Customer Engagement Dispelling Common Myths in Omnichannel Customer Engagement The COVID-19 pandemic has proven that an omnichannel customer engagement strategy is essential. However, determining what “good” omnichannel engagement looks like in the rapidly changing healthcare landscape is no small task. Complicating matters
Conferences New Data in Early Settings and the Continued Development of Immunotherapies Captured Attention during ASCO's 2021 Annual Meeting. Among clinical topics, new data in early settings and continued development of immunotherapies stood out to oncologists as areas that can change their practice in the immediate future.
Customer Engagement Returning to In-Person Promotion: Physician Expectations for Sales Rep Vaccination As the COVID-19 vaccine rollout continues in the United States, sales teams across the pharmaceutical industry are considering how and when to increase the volume of in-person promotion.
Covid-19 COVID-19 Impact: The Future of In-person and Omni-channel Promotion The COVID-19 pandemic led to significant changes in the way pharma engaged with healthcare practitioners (HCPs). To better understand these trends, ZoomRx analyzed over 20,000 sales rep interactions during the COVID-19 pandemic,
Conferences Participant Highlights from AAAAI 2021 Among the specific topics commanding healthcare professionals' (HCP) attention were the potential for Sanofi’s Dupixent in eosinophilic esophagitis, Amgen’s tezepelumab in uncontrolled asthma, and Lilly’s Olumiant in atopic dermatitis.
Covid-19 After Q4 Earnings Calls: Comparing Industry Outlook and Physician Perspectives During Q4 earnings calls, biopharmaceutical companies reflected on the cumulative impact of the COVID-19 pandemic. An assessment of US-based physician sentiment (n=62) provides a useful ‘on-the-ground’ perspective to further examine these issues.
Celebrating International Women's Day 2021 On International Women's Day, ZoomRxers #ChooseToChallenge any gender bias at the workplace. We commit to bringing about change and accelerating gender parity at the workplace.
Research Dermatologists and Rheumatologists Weigh In on Immunology Needs and Shifts in 2021 Across multiple indications, physicians anticipate 2021 will be an exciting year for advancing treatments across autoimmune and auto-inflammatory conditions. In a study conducted by ZoomRx late December 2020, 107 practicing U.S. rheumatologists
Conferences Genome editing using CRISPR and gene therapy captured attention during this year’s fully virtual ASH annual meeting. Early stage data showcasing the potential of both genome editing using CRISPR and gene therapy in non-malignant hematological disorders captured attention during this year’s fully virtual ASH annual meeting. A highlight of
![Empowering a leading biotech manufacturer to make data-backed decisions in the eleventh hour [Case Study]](/content/images/size/w600/2022/09/RT-case---packaging-decisions-01-1.jpg)
